Here is the latest shareholding Pattern of TITAN BIOTEC. For more details, see the TITAN BIOTEC financial fact sheet and TITAN BIOTEC share price.
| No. of Mths Qtr. Ending |
3
Sep-24 |
3
Dec-24 |
3
Mar-25 |
3
Jun-25 |
3
Sep-25 |
3
Dec-25 |
3
Mar-26 |
3
Jun-26 |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Indian Promoters | % | 55.88 | 55.88 | 55.88 | 55.88 | 55.78 | 55.78 | 55.78 | 55.78 | |
| Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Promoters | % | 55.88 | 55.88 | 55.88 | 55.88 | 55.78 | 55.78 | 55.78 | 55.78 | |
| Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other | % | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | |
| Total Institution | % | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | |
| Bodies Corporate | % | 1.73 | 1.72 | 1.84 | 1.84 | 2.18 | 2.12 | 4.37 | 3.38 | |
| Individuals | % | 29.98 | 29.43 | 29.20 | 29.44 | 29.65 | 29.74 | 27.72 | 28.02 | |
| NRIs/OCBs | % | 2.66 | 2.74 | 2.86 | 2.39 | 2.03 | 1.70 | 1.51 | 1.56 | |
| ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Others | % | 9.75 | 10.23 | 10.21 | 10.42 | 10.33 | 10.63 | 10.59 | 11.25 | |
| Total Non-Institution | % | 44.12 | 44.12 | 44.11 | 44.09 | 44.19 | 44.19 | 44.19 | 44.21 | |
| Total Public | % | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | |
| Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
More Chemicals & Pesticides Company Shareholding Pattern: UPL PIDILITE INDUSTRIES HIMADRI SPECIALITY CHEMICAL TATA CHEMICALS FINEOTEX CHEMICAL
The Asian stock markets remained in the bear territory for Thursday as well, as climbing brent rates fogged economic outlook and stoked inflation concerns among investors.